Shingles is a condition associated with a painful blistering rash.It is caused by reactivation of the chicken pox virus. Once you have had chicken pox the virus stays in your body within nerve cells. Later in life, often during times of infection or stress the virus can become active again.
It is estimated that the life time risk of getting shingles is around 1 in 3 . Nearly all adults over 50 have the shingles virus dormant in their nervous system,waiting to reactivate with advancing age.
Shingrix is an inactivated vaccine indicated for people aged 50 years and older. It is the only shingles vaccine to achieve over 90% efficacy in preventing shingles infection and over 88% efficacy at preventing post herpatic neuralgic pain, a complication of the virus. It is a non-live vaccine created to generate a strong and lasting immune response that can help overcome the decline in immunity that occurs as people age.
Manufactured by GSK.
2 doses (0.5ml each) given by intramuscular injection at 0 and 2 to 6 months
Shingrix must not be given to anyone with a history of a severe allergic reaction ( e.g. anaphylaxis)to any component of the vaccine or after a previous dose of shingrix.
The most common side effects are pain,redness and swelling at the injection site, muscle pain,tiredness,headache,shivering,fever and upset stomach.
2 Doses
£225
Registered in England & Wales. Company Number: 9474519. Registered Office: 45 South Street, Dorking, Surrey, RH4 2JX.
